ES2298827T3 - PROCEDURE FOR OBTAINING N-CARBOXIANHYDRIDES FROM ALPHA-AMINO ACIDS PROTECTED WITH URETHANE. - Google Patents
PROCEDURE FOR OBTAINING N-CARBOXIANHYDRIDES FROM ALPHA-AMINO ACIDS PROTECTED WITH URETHANE. Download PDFInfo
- Publication number
- ES2298827T3 ES2298827T3 ES04786315T ES04786315T ES2298827T3 ES 2298827 T3 ES2298827 T3 ES 2298827T3 ES 04786315 T ES04786315 T ES 04786315T ES 04786315 T ES04786315 T ES 04786315T ES 2298827 T3 ES2298827 T3 ES 2298827T3
- Authority
- ES
- Spain
- Prior art keywords
- formula
- nca
- radical
- solvent
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000008206 alpha-amino acids Nutrition 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 31
- 150000001371 alpha-amino acids Chemical class 0.000 title claims description 18
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 title claims description 9
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 claims abstract description 49
- ZFTFAPZRGNKQPU-UHFFFAOYSA-N dicarbonic acid Chemical compound OC(=O)OC(O)=O ZFTFAPZRGNKQPU-UHFFFAOYSA-N 0.000 claims abstract description 16
- 230000003197 catalytic effect Effects 0.000 claims abstract description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 7
- 238000002844 melting Methods 0.000 claims abstract description 4
- 230000008018 melting Effects 0.000 claims abstract description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 3
- 125000000524 functional group Chemical group 0.000 claims abstract description 3
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 34
- -1 alkyl radical Chemical class 0.000 claims description 27
- 239000002904 solvent Substances 0.000 claims description 22
- 239000012429 reaction media Substances 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 9
- 125000001424 substituent group Chemical group 0.000 claims description 9
- 235000001014 amino acid Nutrition 0.000 claims description 8
- 150000001413 amino acids Chemical class 0.000 claims description 8
- 238000001704 evaporation Methods 0.000 claims description 6
- 230000008020 evaporation Effects 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 3
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 3
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 3
- 125000001624 naphthyl group Chemical group 0.000 claims description 3
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 claims description 2
- RMRFFCXPLWYOOY-UHFFFAOYSA-N allyl radical Chemical compound [CH2]C=C RMRFFCXPLWYOOY-UHFFFAOYSA-N 0.000 claims description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 2
- 239000007810 chemical reaction solvent Substances 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 claims description 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims description 2
- 125000006239 protecting group Chemical group 0.000 claims description 2
- WPWHSFAFEBZWBB-UHFFFAOYSA-N 1-butyl radical Chemical compound [CH2]CCC WPWHSFAFEBZWBB-UHFFFAOYSA-N 0.000 claims 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 150000002475 indoles Chemical class 0.000 claims 1
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 abstract description 14
- 239000003960 organic solvent Substances 0.000 abstract description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 16
- 230000015572 biosynthetic process Effects 0.000 description 13
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 11
- 150000003512 tertiary amines Chemical class 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000010647 peptide synthesis reaction Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical group 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- XNCNNYXFGGTEMT-UHFFFAOYSA-N 4-propan-2-yl-1,3-oxazolidine-2,5-dione Chemical compound CC(C)C1NC(=O)OC1=O XNCNNYXFGGTEMT-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 230000001012 protector Effects 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 108010016626 Dipeptides Proteins 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- GQBIVYSGPXCELZ-QMMMGPOBSA-N (4s)-4-benzyl-1,3-oxazolidine-2,5-dione Chemical compound O=C1OC(=O)N[C@H]1CC1=CC=CC=C1 GQBIVYSGPXCELZ-QMMMGPOBSA-N 0.000 description 1
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000005840 aryl radicals Chemical group 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- IRXSLJNXXZKURP-UHFFFAOYSA-N fluorenylmethyloxycarbonyl chloride Chemical compound C1=CC=C2C(COC(=O)Cl)C3=CC=CC=C3C2=C1 IRXSLJNXXZKURP-UHFFFAOYSA-N 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-N sodium;hydron;carbonate Chemical compound [Na+].OC(O)=O UIIMBOGNXHQVGW-UHFFFAOYSA-N 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- UJJDEOLXODWCGK-UHFFFAOYSA-N tert-butyl carbonochloridate Chemical compound CC(C)(C)OC(Cl)=O UJJDEOLXODWCGK-UHFFFAOYSA-N 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/44—Two oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Catalysts (AREA)
Abstract
Procedimiento de obtención de N-carboxianhídridos de alfa-aminoácidos protegidos con uretano (UNCA), de fórmula I (Ver fórmula) en la que R1 y R2, idénticos o diferentes, representan juntos o independientemente uno del otro, un átomo de hidrógeno o una cadena lateral de un alfa-aminoácido natural o sintético portadora eventualmente de grupos funcionales, cuando sea apropiado protegidos; R 3 representa un radical alquilo en C1-C10 saturado o insaturado, lineal o ramificado o un radical aralquilo o alquilarilo en 7 a 14 átomos de carbono, caracterizado porque un N-carboxianhídrido de alfaaminoácido (NCA) de fórmula II (Ver fórmula) en la que R1 y R2 tienen el mismo significado que para la fórmula I, se hace reaccionar con al menos un equivalente, con relación a la cantidad molar involucrada de NCA de fórmula II, de dicarbonato de fórmula III (Ver fórmula) en la que R3 tiene el mismo significado que para la fórmula I, en presencia de una cantidad catalítica de 1,4-diazabiciclo[2.2.2]octano, denominado asimismo trietilendiamina (TEDA), con relación a la cantidad molar involucrada de NCA de fórmula II, en un disolvente orgánico, con un punto de fusión inferior a aproximadamente -20ºC.Procedure for obtaining urethane-protected alpha-amino acid N-carboxyanhydrides (UNCA), of formula I (See formula) in which R1 and R2, identical or different, together or independently represent one another, a hydrogen atom or a side chain of a natural or synthetic alpha-amino acid eventually carrying functional groups, when appropriate protected; R 3 represents a saturated or unsaturated, linear or branched C1-C10 alkyl radical or an aralkyl or alkylaryl radical having 7 to 14 carbon atoms, characterized in that an alpha-amino acid N-carboxyanhydride (NCA) of formula II (See formula) in that R1 and R2 have the same meaning as for formula I, is reacted with at least one equivalent, relative to the molar amount involved of NCA of formula II, of dicarbonate of formula III (See formula) in which R3 it has the same meaning as for formula I, in the presence of a catalytic amount of 1,4-diazabicyclo [2.2.2] octane, also called triethylenediamine (TEDA), in relation to the molar amount involved of NCA of formula II, in an organic solvent, with a melting point of less than about -20 ° C.
Description
Procedimiento de obtención de N-carboxianhídridos de alfa-aminoácidos protegidos con uretano.Procedure for obtaining N-carboxyanhydrides of urethane protected alpha-amino acids.
La presente invención se refiere a un nuevo procedimiento de preparación de N-carboxianhídridos de alfa-aminoácidos protegidos con uretano. El nuevo procedimiento permite la síntesis de N-carboxianhídridos de alfa-aminoácidos protegidos con uretano a partir de N-carboxianhídridos de alfa-aminoácidos en presencia de una cantidad catalítica de trietilendiamina, sin adición de cantidades significativas de una base del tipo amina terciaria.The present invention relates to a new N-carboxyanhydride preparation process of urethane protected alpha-amino acids. He new procedure allows the synthesis of N-carboxyanhydrides of urethane protected alpha-amino acids from N-carboxyanhydrides of alpha-amino acids in the presence of an amount triethylenediamine catalyst, without adding amounts significant of a tertiary amine type base.
Los N-carboxianhídridos de los alfa-aminoácidos (a continuación designados bajo la abreviatura NCA), opcionalmente protegidos, son unos agentes de acilación usados frecuentemente para la formación de poli alfa-aminoácidos de alto peso molecular y para la producción de dipéptidos. Los NCA son unos compuestos muy reactivos, que no forman, en particular a través de re-configuración, ningún producto secundario no deseado y cuyo único subproducto de reacción es el dióxido de carbono. Cuando el NCA se pone a reaccionar con una función amina libre de un aminoácido, se libera inmediatamente dióxido de carbono y se forma un dipéptido, que contiene a su vez una función amina libre. Esta amina reaccionará con NCA para formar un tripéptido, y así sucesivamente. Así, los NCA se pueden usar en la formación de poli(alfa-aminoácidos) pero no se pueden usar fácilmente en la síntesis secuencial de polipéptidos, siendo difíciles de controlar las reacciones secundarias múltiples de condensación tal como una oligomerización.The N-carboxyanhydrides of alpha-amino acids (below designated under the NCA abbreviation), optionally protected, are agents of acylation frequently used for poly formation high molecular weight alpha-amino acids and for the dipeptide production. NCAs are very reactive compounds, that do not form, particularly through re-configuration, no secondary product not desired and whose only reaction byproduct is the dioxide of carbon. When the NCA reacts with an amine function free of an amino acid, carbon dioxide is released immediately and a dipeptide is formed, which in turn contains an amine function free. This amine will react with NCA to form a tripeptide, and so on. Thus, NCAs can be used in the formation of poly (alpha-amino acids) but cannot be used easily in sequential polypeptide synthesis, being difficult to control multiple side reactions of condensation such as oligomerization.
Se han descrito en la bibliografía N-carboxianhídridos de alfa-aminoácidos sustituidos por unos grupos uretano, y se usan en las síntesis peptídicas. El sustituyente uretano aporta un alto grado de protección y permite minimizar las reacciones de polimerización durante la reacción de acoplamiento. Los NCA protegidos con uretano, abreviados como UNCA a continuación, presentan todas las ventajas de los NCA no sustituidos sin los inconvenientes de estos últimos.They have been described in the bibliography N-carboxyanhydrides of alpha-amino acids substituted by groups urethane, and are used in peptide syntheses. The substituent urethane provides a high degree of protection and minimizes the polymerization reactions during the coupling reaction. UCAs protected with urethane, abbreviated as UNCA to They then present all the advantages of unsubstituted NCAs without the inconvenience of the latter.
Los UNCA permiten una síntesis controlada de polipéptidos sin que sea necesaria ninguna pre-activación de los grupos carboxilo, y sin que sea necesaria ninguna adición de aditivos tales como el N-hidroxibenzotriazol. De esta forma, se facilita la purificación de los péptidos preparados en disolución, debido a que solamente el subproducto de la reacción de síntesis peptídica es el dióxido de carbono.UNCA allows a controlled synthesis of polypeptides without requiring any pre-activation of carboxyl groups, and without no addition of additives such as the N-hydroxybenzotriazole. In this way, it is facilitated the purification of the peptides prepared in solution, due to that only the byproduct of the peptide synthesis reaction It is carbon dioxide.
Los UNCA son muy útiles asimismo como materias primas en la síntesis de hormonas o de medicamentos anti-sida.UNCAs are also very useful as subjects premiums in the synthesis of hormones or medications anti-AIDS
Los UNCA, que están en forma cristalina en condiciones de temperatura y de presión ambientales, son estables bajo las condiciones estándares de manipulación en laboratorio, almacenamiento, y bajo las condiciones de síntesis peptídica.The UNCA, which are in crystalline form in ambient temperature and pressure conditions are stable under standard laboratory handling conditions, storage, and under the conditions of peptide synthesis.
Las dos vías principales de síntesis de los UNCA a partir de NCA son las siguientes:The two main routes of synthesis of the UNCA as of NCA they are the following:
1) Los UNCA se pueden sintetizar por condensación de un cloroformiato de alquilo o de aralquilo, tal como Fmoc-Cl (cloroformiato de 9-fluorofenilmetiloxicarbonilo) o cloroformiato de bencilo, con un NCA en presencia de por lo menos una cantidad estequiométrica de una amina terciaria. Esta amina terciaria, que es habitualmente la N-metilmorfolina, permite depurar el ácido clorhídrico liberado. Así, el NCA se pone en disolución en un disolvente inerte, tal como THF, y se enfría. Se añadieron 1,1 a 1,3 equivalentes de cloroformiato de alquilo o de aralquilo de una sola vez, y después se añadieron lentamente al menos 1,5 equivalentes de una amina terciaria, por ejemplo la N-metilmorfolina. La suspensión resultante se dejó en reposo durante 1 a 2 horas, a una temperatura comprendida entre -25 y -5ºC. Después, se añadió lentamente ácido clorhídrico disuelto en dioxano hasta la obtención de valores de pH de aproximadamente 4-5. El clorhidrato de la amina terciaria así formado se eliminó mediante filtración, y el UNCA se concentró y después se cristalizó.1) UNCA can be synthesized by condensation of an alkyl or aralkyl chloroformate, such as Fmoc-Cl (chloroformate 9-fluorophenylmethyloxycarbonyl) or chloroformate benzyl, with an NCA in the presence of at least a quantity stoichiometric of a tertiary amine. This tertiary amine, which is N-methylmorpholine usually allows to purify the hydrochloric acid released. Thus, the NCA is dissolved in an inert solvent, such as THF, and is cooled. 1.1 a were added 1.3 equivalents of alkyl or aralkyl chloroformate of one only once, and then at least 1.5 were slowly added equivalents of a tertiary amine, for example the N-methylmorpholine. The resulting suspension was left at rest for 1 to 2 hours, at a temperature between -25 and -5ºC. Then, hydrochloric acid was added slowly dissolved in dioxane until obtaining pH values of approximately 4-5. Amine Hydrochloride Tertiary thus formed was removed by filtration, and UNCA was concentrated and then crystallized.
Todas las etapas del procedimiento se llevan a cabo bajo una atmósfera inerte (N_{2}), y todos los disolventes se secan en un tamiz molecular de 4 \ring{A} antes de ser utilizados (William D. Fuller et al., Urethane-protected-alpha-amino acid N-carboxyanhydrides and peptide synthesis, Biopolymers, 1996, 40, 183-205).All steps of the process are carried out under an inert atmosphere (N 2), and all solvents are dried in a 4 molecular molecular sieve before being used (William D. Fuller et al ., Urethane-protected-alpha-amino acid N-carboxyanhydrides and peptide synthesis, Biopolymers , 1996, 40, 183-205).
Esta vía de síntesis es poco apropiada para preparar ciertos N-carboxianhídridos de alfa-aminoácido protegidos, en particular los protegidos por un radical t-butoxicarbonilo, siendo el cloroformiato de t-butilo muy inestable por encima de -20ºC o en presencia de aminas terciarias.This route of synthesis is not appropriate for prepare certain N-carboxyanhydrides of protected alpha-amino acid, particularly those protected by a t-butoxycarbonyl radical, being t-butyl chloroformate very unstable for above -20 ° C or in the presence of tertiary amines.
2) Los UNCA se pueden sintetizar asimismo mediante condensación de un dicarbonato de dialquilo con un NCA. Esta reacción libera una molécula de alcohol y una molécula de dióxido de carbono. Esta síntesis se debe realizar imperativamente en presencia de una cantidad elevada, por lo menos una cantidad de 50% molar con relación a la cantidad molar de NCA involucrada, de una amina terciaria tal como la N-metilmorfolina asociada con una cantidad catalítica de DMAP (4-dimetilaminopiridina) o una piridina (William D. Fuller et al., Urethane-protected-alpha-amino acid N-carboxyan hydrides and peptide synthesis, Biopolymers, 1996, 40, 183-205). Esta vía de síntesis está particularmente adaptada para la síntesis de N-carboxianhídridos de alfa-aminoácidos protegidos por un radical di-butoxicarbonilo utilizando el dicarbonato de di-terciobutildicarbonato, véase asimismo Bull. Cham. Soc. Japón, 69 (1996), 2309-2316.2) UNCAs can also be synthesized by condensing a dialkyl dicarbonate with an NCA. This reaction releases a molecule of alcohol and a molecule of carbon dioxide. This synthesis must be performed imperatively in the presence of a high amount, at least an amount of 50% molar relative to the molar amount of NCA involved, of a tertiary amine such as N-methylmorpholine associated with a catalytic amount of DMAP ( 4-dimethylaminopyridine) or a pyridine (William D. Fuller et al ., Urethane-protected-alpha-amino acid N-carboxyan hydrides and peptide synthesis, Biopolymers , 1996, 40, 183-205). This synthetic route is particularly adapted for the synthesis of N-carboxyanhydrides of alpha-amino acids protected by a di-butoxycarbonyl radical using di-third-butyldicarbonate dicarbonate, see also Bull. Cham Soc. Japan, 69 (1996), 2309-2316.
La solicitud WO 89/08643 describe N-carboxianhídridos de alfa alfa-aminoácidos y N-tiocarboxianhídridos de alfa-aminoácidos con protección de uretano, de fórmula,Application WO 89/08643 describes Alpha N-carboxyanhydrides alpha-amino acids and N-thiocarboxyanhydrides of urethane-protected alpha-amino acids, from formula,
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
en la que R y R' representan un átomo de hidrógeno, un radical alquilo, cicloaquilo, cicloalquilo sustituido por un radical alquilo sustituido, arilo o arilo sustituido, y al menos un grupo R o R' no representa un átomo de hidrógeno; R'' representa un radical alquilo, arilo, alquilo sustituido, o arilo sustituido; Z representa un átomo de oxígeno o de azufre y n es 0, 1 ó 2.in which R and R 'represent a hydrogen atom, an alkyl, cycloalkyl, cycloalkyl radical substituted by a substituted alkyl, aryl or aryl radical substituted, and at least one R or R 'group does not represent an atom of hydrogen; R '' represents an alkyl, aryl, alkyl radical substituted, or substituted aryl; Z represents an oxygen atom or of sulfur and n is 0, 1 or 2.
Estos compuestos se preparan mediante reacción de NCA con un halogenoformato en un disolvente inerte, tal como el tolueno, en condiciones anhidras, en presencia de una base de tipo amina terciaria añadida en exceso.These compounds are prepared by reaction of NCA with a halogenoformate in an inert solvent, such as toluene, under anhydrous conditions, in the presence of a type base tertiary amine added in excess.
Los procedimientos existentes de síntesis de UNCA no resultan satisfactorios. En efecto, el mejor procedimiento descrito anteriormente en la presente memoria, que usa una base de tipo amina terciaria en una cantidad al menos igual a 50% molar con relación a la cantidad de NCA involucrado, proporciona unos rendimientos sólo de aproximadamente 60%, con la condición de que los disolventes se sequen sobre un tamiz molecular de 4 \ring{A} y que sean tratados entre -20 y -15ºC.The existing synthesis procedures of UNCA are not satisfactory. Indeed, the best procedure described above herein, which uses a base of tertiary amine type in an amount at least equal to 50% molar with relation to the amount of NCA involved, provides some yields only of approximately 60%, with the condition that The solvents are dried on a 4 Å molecular sieve and that they are treated between -20 and -15ºC.
Sorprendentemente, se ha descubierto que el uso de trietilendiamina (TEDA) en una cantidad catalítica muy baja, inferior a 5% molar con relación a la cantidad molar de NCA involucrado, sin ninguna adición de base de tipo amina terciaria, lleva a buenos resultados.Surprisingly, it has been discovered that the use of triethylene diamine (TEDA) in a very low catalytic amount, less than 5% molar relative to the molar amount of NCA involved, without any addition of tertiary amine type base, It leads to good results.
En el ámbito de la presente invención, la
abreviatura NCA designa lo(s)
N-carboxianhídrido(s) de
alfa-aminoá-
cido(s) y UNCA designa
lo(s) N-carboxianhídrido(s) de
alfa-aminoácido(s) protegidos con
uretano.Within the scope of the present invention, the abbreviation NCA designates the alpha-amino acid N-carboxyanhydride (s)
acid (s) and UNCA designates the N-carboxyanhydride (s) of urethane-protected alpha-amino acid (s).
En el sentido de la presente invención, mediante la expresión "cantidad catalítica" se entiende una cantidad significativamente inferior y más específicamente inferior en 50% a la requerida por la estequiometría.In the sense of the present invention, by the term "catalytic amount" means an amount significantly lower and more specifically 50% lower at that required by stoichiometry.
La presente invención se refiere a un procedimiento de obtención de N-carboxianhídridos de alfa-aminoácidos protegidos con uretano (UNCA), de fórmula IThe present invention relates to a procedure for obtaining N-carboxyanhydrides from urethane protected alpha-amino acids (UNCA), from formula I
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
en la que R^{1} y R^{2}, idénticos o diferentes, representan juntos o independientemente uno del otro, un átomo de hidrógeno o una cadena lateral de un alfa-aminoácido natural o sintético portadora eventualmente de grupos funcionales, cuando sea apropiado protegidos; R^{3} representa un radical alquilo lineal en C_{1}-C_{10} saturado o insaturado, lineal o ramificado o un radical aralquilo o alcarilo de 7 a 14 átomos de carbono, caracterizado porque un N-carboxianhídrido de alfa-aminoácido (NCA) de la fórmula II,in which R1 and R2, identical or different, together or independently represent one of the other, a hydrogen atom or a side chain of a natural or synthetic alpha-amino acid carrier possibly from functional groups, when appropriate protected; R 3 represents a linear alkyl radical in C 1 -C 10 saturated or unsaturated, linear or branched or an aralkyl or alkaryl radical of 7 to 14 atoms of carbon, characterized in that an N-carboxyanhydride of alpha-amino acid (NCA) of the formula II,
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
en la que R^{1} y R^{2} tienen el mismo significado que para la fórmula I, se hace reaccionar con al menos un equivalente, con relación a la cantidad molar involucrada de NCA de fórmula II, de dicarbonato de fórmula IIIin which R1 and R2 have the same meaning as for formula I, is reacted with at least one equivalent, in relation to the molar quantity involved in NCA of formula II, of dicarbonate of formula III
en la que R^{3} tiene el mismo significado que para la fórmula I, en presencia de una cantidad catalítica de 1,4-diazabiciclo[2.2.2]octano, denominado asimismo trietilendiamina (TEDA), con relación a la cantidad molar involucrada de NCA de la fórmula II, en un disolvente orgánico inerte con un punto de fusión inferior a aproximadamente -20ºC.in which R3 has the same meaning that for formula I, in the presence of an amount catalytic of 1,4-diazabicyclo [2.2.2] octane, also called triethylene diamine (TEDA), in relation to molar amount involved of NCA of formula II, in a inert organic solvent with a melting point lower than approximately -20 ° C.
Un alfa-aminoácido natural o sintético es un aminoácido portador en el primer carbono de la cadena de una función amina y de una función de ácido carboxílico. El resto del alfa-aminoácido se denomina cadena lateral del alfa-aminoácido.A natural alpha-amino acid or synthetic is a carrier amino acid in the first carbon of the chain of an amine function and a carboxylic acid function. The rest of the alpha-amino acid is called a chain side of the alpha-amino acid.
R1 y R2 son, cuando es apropiado, protegidos con grupos protectores usados habitualmente en el campo de los aminoácidos y de los péptidos (Bodansky, principles of peptide synthesis, Springer-Verlag, 1984; Alpha amino-acids N-carboxyanhydrides and related heterocycles, Hans R. Kricheldorf, Springer Verlag, 1987).R1 and R2 are, when appropriate, protected with protective groups commonly used in the field of amino acids and peptides (Bodansky, principles of peptide synthesis, Springer-Verlag , 1984; Alpha amino acids N-carboxyanhydrides and related heterocycles, Hans R. Kricheldorf, Springer Verlag, 1987).
R1 y R2, idénticos o diferentes, representan ventajosamente un átomo de hidrógeno, un radical alquilo en C_{1}-C_{8} lineal o ramificado, que comprende eventualmente uno o más sustituyente(s) habitual(es) en el campo de los aminoácidos y de los péptidos. Los sustituyentes se seleccionan en particular de entre el grupo constituido por OH, SH, NH_{2}, NHC(NH)NH_{2}, CONH_{2}, O-alquilo en C_{1}-C_{6}, O-arilo en C_{6}-C_{10}, S-alquilo en C_{1}-C_{6}, COO-alquilo en C_{1}-C_{6}, COO-aralquilo en C_{5}-C_{8}, en particular el radical éster bencílico.R1 and R2, identical or different, represent advantageously a hydrogen atom, an alkyl radical in C 1 -C 8 linear or branched, comprising possibly one or more usual substituent (s) in the field of amino acids and peptides. Substituents they are selected in particular from the group consisting of OH, SH, NH2, NHC (NH) NH2, CONH2, O-C 1 -C 6 alkyl, O-aryl in C 6 -C 10, S-C 1 -C 6 alkyl, COO-C 1 -C 6 alkyl, COO-aralkyl in C 5 -C 8, in Particularly the benzyl ester radical.
Un grupo R1 o R2 puede representar ventajosamente un radical cicloalquilo en C_{5}-C_{7}, sustituido opcionalmente por uno o más grupo(s) habitual(es) en el campo de los aminoácidos y de los péptidos. Los sustituyentes se seleccionan en particular de entre el grupo constituido por los halógenos, OH, O-alquilo en C_{1}-C_{6}, O-arilo en C_{6}-C_{10}, alquilo en C_{1}-C_{6}.A group R1 or R2 can represent advantageously a cycloalkyl radical in C 5 -C 7, optionally substituted by one or more usual group (s) in the field of amino acids and peptides. Substituents are selected in particular among the group consisting of halogens, OH, O-C 1 -C 6 alkyl, C 6 -C 10 O-aryl, alkyl in C_ {1} -C_ {6}.
Un grupo R1 o R2 puede representar ventajosamente un radical fenilo, naftilo, heteroaromático de 5 ó 6 miembros o indol eventualmente sustituido con uno o más grupo(s) habitual(es) en el campo de los aminoácidos y de los péptidos. Los sustituyentes se seleccionan en particular de entre el grupo constituido por los halógenos, OH, O-alquilo en C_{1}-C_{6}, O-arilo en C_{6}-C_{10}, alquilo en C_{1}-C_{6}.A group R1 or R2 can represent advantageously a phenyl, naphthyl, heteroaromatic radical of 5 or 6 members or indole eventually replaced with one or more usual group (s) in the field of amino acids and of the peptides. The substituents are selected in particular from among the group consisting of halogens, OH, O-C 1 -C 6 alkyl, C 6 -C 10 O-aryl, alkyl in C_ {1} -C_ {6}.
Por razones obvias de obstáculos estéricos, R1 y R2 no pueden representar simultáneamente un radical cíclico. Mediante la expresión "radical cíclico" se entiende dicho radical cicloalquilo en C_{5}-C_{7} así como dicho radical fenilo, naftilo, o heteroaromático de 5 ó 6 miembros o indol.For obvious reasons of steric obstacles, R1 and R2 cannot simultaneously represent a cyclic radical. The term "cyclic radical" means said C 5 -C 7 cycloalkyl radical as well as said 5 or 6 membered phenyl, naphthyl, or heteroaromatic radical or indole
R^{1} y R^{2} pueden formar asimismo juntos un radical cicloalquilo en C_{5}-C_{7} sustituido eventualmente con uno o más grupo(s) habitual(es) en el campo de los aminoácidos y de los péptidos. Los grupos se seleccionan en particular de entre el grupo constituido por los halógenos, OH, O-alquilo en C_{1}-C_{6}, alquilo en C_{1}-C_{6}, O-arilo en C_{6}-C_{10}.R1 and R2 can also form together a C 5 -C 7 cycloalkyl radical eventually replaced with one or more group (s) usual (s) in the field of amino acids and peptides Groups are selected in particular from the group constituted by halogens, OH, O-alkyl in C 1 -C 6, alkyl in C 1 -C 6, O-aryl in C_ {6} -C_ {10}.
En el caso en el que R1 y R2 no forman juntos un radical cicloalquilo en C_{5}-C_{7}, por lo menos uno de los grupos R1 y R2, tales como se han definido anteriormente, representa ventajosamente un átomo de hidrógeno.In the case where R1 and R2 do not together form a C 5 -C 7 cycloalkyl radical, so minus one of the groups R1 and R2, as defined above, it advantageously represents a hydrogen atom.
En los compuestos de la fórmula II, los grupos funcionales están protegidos ventajosamente con unos grupos protectores adecuados.In the compounds of formula II, the groups functional are advantageously protected with groups adequate protectors.
Según una variante ventajosa de la invención, R3 representa el radical metilo, el radical etilo, el radical tercio-butilo, el radical bencilo, el radical alilo o el radical 9-fluorenilmetilo. En efecto, aunque existe una gran variedad de uretanos que se pueden usar como grupos protectores, sólo unos cuantos se usan ampliamente en la síntesis peptídica. Se pueden citar en particular T-butiloxicarbonilo (Boc), benciloxicarbonilo (Cbz) y 9-fluorenilmetiloxicarbonilo (Fmoc). Por consiguiente, los N-carboxianhídridos de alfa-aminoácidos protegidos por estos sustituyentes son particularmente interesantes.According to an advantageous variant of the invention, R3 represents the methyl radical, the ethyl radical, the radical third-butyl, the benzyl radical, the allyl radical or the 9-fluorenylmethyl radical. Indeed though there is a great variety of urethanes that can be used as groups protectors, only a few are widely used in synthesis peptide They can be cited in particular T-butyloxycarbonyl (Boc), benzyloxycarbonyl (Cbz) and 9-fluorenylmethyloxycarbonyl (Fmoc). By consequently, the N-carboxyanhydrides of alpha-amino acids protected by these substituents They are particularly interesting.
\global\parskip0.950000\baselineskip\ global \ parskip0.950000 \ baselineskip
El procedimiento según la presente invención permite evitar el uso de una amina terciaria, en una cantidad muy elevada de 50 a 200% molar con relación a la cantidad molar de NCA involucrado. Las aminas terciarias usadas en la técnica anterior, la N-metilmorfolina y la piridina, plantean realmente numerosos problemas. De forma especial, su uso implica trabajar con una alta dilución, la formación de productos parásitos, una etapa adicional de separación, un reciclaje difícil y, además, resulta muy costoso.The process according to the present invention it allows to avoid the use of a tertiary amine, in a very quantity raised from 50 to 200% molar relative to the molar amount of NCA involved. Tertiary amines used in the prior art, N-methylmorpholine and pyridine, pose Really numerous problems. Especially, its use implies work with a high dilution, the formation of parasitic products, an additional stage of separation, difficult recycling and, in addition, It is very expensive.
El procedimiento según la invención permite asimismo reducir notablemente los tiempos de reacción que son a partir de ahora menores que 24 horas y ventajosamente del orden de 1 a 4 horas, mientras que para los procedimientos de la técnica anterior, los tiempos de reacción variaban de 30 horas a 5 días.The process according to the invention allows also significantly reduce reaction times that are a from now less than 24 hours and advantageously of the order of 1 to 4 hours, while for technique procedures Previously, reaction times varied from 30 hours to 5 days.
El procedimiento según la invención permite obtener UNCA, cuya pureza medida mediante GPC (cromatografía fase gaseosa) es superior a 90%, ventajosamente superior a 95%, con un rendimiento muy satisfactorio, superior a 60% en masa.The process according to the invention allows obtain UNCA, whose purity measured by GPC (phase chromatography soda) is greater than 90%, advantageously greater than 95%, with a Very satisfactory yield, greater than 60% by mass.
Según una variante ventajosa de la invención, el disolvente se selecciona del grupo constituido por éteres en C_{4}-C_{10} cíclicos o lineales, y por alcanos en C_{1}-C_{5} clorados. Ventajosamente, el disolvente es el THF (tetrahidrofurano).According to an advantageous variant of the invention, the solvent is selected from the group consisting of ethers in C_ {4} -C_ {10} cyclic or linear, and by alkanes in C 1 -C 5 chlorinated. Advantageously, the Solvent is THF (tetrahydrofuran).
Cuando el disolvente de la reacción es el THF, la cantidad de disolvente introducido está comprendida generalmente entre 500 g y 2 kg de disolvente por mol de NCA de fórmula II involucrado.When the reaction solvent is THF, the amount of solvent introduced is generally comprised between 500 g and 2 kg of solvent per mole of NCA of formula II involved.
Según una variante ventajosa del procedimiento según la presente invención, la cantidad introducida de TEDA está comprendida entre 0,1 y 5% molar de TEDA, con relación a la cantidad molar involucrada de NCA de fórmula II. Aún más ventajosamente, la cantidad introducida de TEDA está comprendida entre 0,2% y 1% molar, con relación a la cantidad molar involucrada de NCA de fórmula II.According to an advantageous variant of the procedure According to the present invention, the introduced amount of TEDA is between 0.1 and 5 molar% of TEDA, in relation to the quantity molar involved of NCA of formula II. Even more advantageously, the introduced amount of TEDA is between 0.2% and 1% molar, in relation to the molar amount involved of NCA of formula II.
El NCA de fórmula II se hace reaccionar ventajosamente con 1,1 a 1,5 equivalentes de dicarbonato de fórmula III en presencia de TEDA, en particular en presencia de 0,2% a 1% molar de TEDA con relación a la cantidad molar involucrada de NCA de fórmula II.The NCA of formula II is reacted advantageously with 1.1 to 1.5 equivalents of dicarbonate of formula III in the presence of TEDA, in particular in the presence of 0.2% to 1% molar of TEDA in relation to the molar amount involved of NCA of formula II.
El dicarbonato de fórmula III se introduce ventajosamente, en forma de una disolución, en una parte del disolvente, ventajosamente en 0,5 a 2,0 partes en peso con relación a la cantidad total en peso involucrada de dicarbonato, de forma regular en el medio de reacción que comprende la otra parte necesaria del disolvente, el NCA de fórmula II que se va a transformar y el TEDA. Durante la introducción del dicarbonato, la temperatura del medio de reacción se mantiene entre -20 y 5ºC, ventajosamente entre -15 y 5ºC, y aún más ventajosamente entre -10 y 0ºC. Según una variante ventajosa de la invención, la reacción se realiza en una atmósfera inerte.The dicarbonate of formula III is introduced advantageously, in the form of a solution, in a part of the solvent, advantageously in 0.5 to 2.0 parts by weight in relation to to the total amount of weight involved in dicarbonate, so regulate in the reaction medium comprising the other part of the solvent, the NCA of formula II to be transform and TEDA. During the introduction of dicarbonate, the reaction medium temperature is maintained between -20 and 5 ° C, advantageously between -15 and 5 ° C, and even more advantageously between -10 and 0 ° C According to an advantageous variant of the invention, the reaction is Performs in an inert atmosphere.
El efecto catalítico del TEDA permite una técnica de introducción gradual del dicarbonato en el medio de reacción, lo que permite el control de la exotermicidad mediante la detención de la introducción, evitando así cualquier riesgo de una reacción descontrolada peligrosa.The catalytic effect of TEDA allows a technique of gradual introduction of dicarbonate in the middle of reaction, which allows the control of exothermicity by stopping the introduction, thus avoiding any risk of a dangerous uncontrolled reaction.
El procedimiento permite trabajar en un medio mucho más concentrado que, acoplado con tiempos de reacción reducidos, permite una ganancia substancial en la productividad y limita mucho los riesgos de polimerización.The procedure allows working in a medium much more concentrated than, coupled with reaction times reduced, allows a substantial gain in productivity and It greatly limits the risks of polymerization.
Al final de la adición del dicarbonato de fórmula III, el medio de reacción se deja ventajosamente bajo agitación, durante al menos 30 minutos a una temperatura comprendida entre -5 y 10ºC.At the end of the addition of the dicarbonate of formula III, the reaction medium is left advantageously low stirring, for at least 30 minutes at a temperature between -5 and 10ºC.
Al final de la adición del dicarbonato de fórmula III, en cuanto el medio de reacción se ha dejado opcionalmente bajo agitación, el medio de reacción se filtra, y después se elimina al menos 80%, de forma ventajosa aproximadamente 90%, del disolvente mediante evaporación a presión reducida. Después, se añade un compuesto no-disolvente en una cantidad preferentemente equivalente a la cantidad de disolvente de reacción eliminada mediante evaporación, a fin de precipitar el UNCA de fórmula I, el cual se recupera después mediante filtración, cuando sea apropiado, después de la eliminación de dichos grupos protectores adaptados.At the end of the addition of the dicarbonate of formula III, as soon as the reaction medium has been left optionally under stirring, the reaction medium is filtered, and then at least 80% is removed, advantageously approximately 90% of the solvent by evaporation under reduced pressure. Then, a non-solvent compound is added in a amount preferably equivalent to the amount of solvent of reaction removed by evaporation, in order to precipitate the UNCA of formula I, which is then recovered by filtration, when appropriate, after the removal of such groups adapted protectors.
Según una variante de la invención, el disolvente se elimina mediante evaporación a presión reducida a una temperatura comprendida entre 15 y 30ºC, ventajosamente a temperatura ambiente.According to a variant of the invention, the solvent is removed by evaporation under reduced pressure at a temperature between 15 and 30 ° C, advantageously at room temperature.
El compuesto no-disolvente de UNCA es ventajosamente un alcano en C_{5}-C_{10} lineal o ramificado, en particular el heptano B.The non-solvent compound of UNCA is advantageously an alkane in C_ {5} -C_ {10} linear or branched, in particular heptane B.
Según una variante de la invención, el precipitado se seca después al vacío a una temperatura inferior a 30ºC.According to a variant of the invention, the precipitate is then dried under vacuum at a temperature below 30 ° C
Los siguientes ejemplos ilustran la presente invención y no son limitativos.The following examples illustrate the present invention and are not limiting.
Ejemplo 1Example one
La abreviatura Val representa el alfa-aminoácido valina. Val-NCA representa por lo tanto el compuesto de la fórmula siguiente:The abbreviation Val represents the alpha-amino acid valine. Val-NCA therefore represents the compound of the following formula:
\global\parskip1.000000\baselineskip\ global \ parskip1.000000 \ baselineskip
En un reactor de 1 litro de doble cámara, equipado con un criotermostato, un embudo, un sistema de circulación de nitrógeno, una agitación mecánica y una sonda termométrica, se introducen, después de obtener un ambiente inerte con nitrógeno y de enfriar a -5 \pm 2ºC:In a 1 liter double chamber reactor, equipped with a cryotmostat, a funnel, a circulation system of nitrogen, a mechanical stirring and a thermometric probe, it introduce, after obtaining an inert environment with nitrogen and cooling to -5 ± 2 ° C:
- 204 g de THF,- 204 g of THF,
- 37,5 g (0,26 moles) de Val-NCA,- 37.5 g (0.26 mol) of Val-NCA,
- 0,15 g (1,3 mmoles) de TEDA.- 0.15 g (1.3 mmol) of TEDA.
Se agita el medio de reacción durante ½ hora, y después se introduce lentamente una disolución de 69 g (0,316 moles) de (Boc)_{2}O en 50 g de THF durante 2 horas mediante un embudo de goteo, regulando la temperatura a -5ºC \pm 2ºC. Aparece una ligera liberación de gas.The reaction medium is stirred for ½ hour, and then a solution of 69 g (0.316) is slowly introduced moles) of (Boc) 2 O in 50 g of THF for 2 hours by means of a drip funnel, regulating the temperature at -5ºC ± 2 ° C A slight gas release appears.
El medio de reacción se mantiene bajo agitación durante 1 hora después del final del goteo de (Boc)_{2}O.The reaction medium is kept under stirring. for 1 hour after the end of the drip of (Boc) 2 O.
El medio de reacción se filtra a 0ºC en una pre-capa inerte montada con THF y el reactor se enjuaga así como la pre-capa inerte con 50 ml de THF.The reaction medium is filtered at 0 ° C in a inert pre-layer mounted with THF and the reactor is rinse as well as the inert pre-layer with 50 ml of THF.
Los filtrados se vuelven a colocar en el reactor de doble cámara todavía bajo nitrógeno y se destilan 300 ml de THF a una temperatura de medio de reacción de 18 a 26ºC con una presión de 140 a 160 milibares.The filtrates are put back in the reactor double chamber still under nitrogen and 300 ml of THF are distilled at a reaction medium temperature of 18 to 26 ° C with a pressure from 140 to 160 millibars.
Se añaden 300 ml (215 g) de heptano B a una temperatura de 25ºC. El producto UNCA de valina precipita. Después, se destilan 300 ml de mezcla THF/heptano B a 25ºC con 900-100 milibares hasta un volumen de medio de reacción de aproximadamente 100 ml. Después, se añaden 200 ml de heptano B a una temperatura de aproximadamente 25ºC. El medio de reacción se deja enfriar hasta -10ºC, temperatura que se mantiene durante 1 hora. La filtración se realiza en un filtro nº 3 sinterizado, en una atmósfera de nitrógeno a -10ºC. El producto se seca en un horno al vacío a una temperatura de 25 \pm 5ºC.300 ml (215 g) of heptane B are added to a temperature of 25 ° C. The UNCA product of valine precipitates. After, 300 ml of THF / heptane B mixture is distilled at 25 ° C with 900-100 millibars up to an average volume of reaction of approximately 100 ml. Then, 200 ml of heptane B at a temperature of approximately 25 ° C. The middle of reaction is allowed to cool to -10 ° C, temperature maintained for 1 hour. Filtration is performed on a filter # 3 sintered, in a nitrogen atmosphere at -10 ° C. The product is Dry in a vacuum oven at a temperature of 25 ± 5 ° C.
Así, se obtienen 51,6 g (rendimiento de 80,8%) de un polvo blanco con poder giratorio de 59,1º (C = 1, THF) cuya pureza medida mediante GPC es de 100%.Thus, 51.6 g (yield 80.8%) are obtained. of a white powder with rotating power of 59.1º (C = 1, THF) whose Purity measured by GPC is 100%.
Ejemplo 2Example 2
La abreviatura Ile representa el alfa-aminoácido isoleucina. Ile-NCA representa por lo tanto el compuesto de la fórmula siguiente:The abbreviation Ile represents the alpha-amino acid isoleucine. Ile-NCA therefore represents the compound of the following formula:
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Se procede como en el ejemplo 1 con:Proceed as in example 1 with:
- 200,9 g de THF,- 200.9 g of THF,
- 40,0 g (0,255 moles) de Ile-NCA,- 40.0 g (0.255 mol) of Ile-NCA,
- 0,14 g (1,3 mmoles) de TEDA,- 0.14 g (1.3 mmol) of TEDA,
y una disolución de 66 g (0,302 moles) de (Boc)_{2}O en 66 g de THF.and a solution of 66 g (0.302 mol) of (Boc) 2 O in 66 g of THF.
Después de la filtración y del secado, se recuperan 51,5 g (rendimiento de 78,6%) del producto esperado, con un punto de fusión de 107,6ºC y cuyo poder giratorio es de 60,3º (C = 1, THF). La pureza medida mediante GPC es de 99,3%.After filtration and drying, it is recover 51.5 g (yield 78.6%) of the expected product, with a melting point of 107.6 ° C and whose rotating power is 60.3 ° (C = 1, THF). The purity measured by GPC is 99.3%.
Ejemplo 3Example 3
La abreviatura Phe representa el alfa-aminoácido fenilalanina. Phe-NCA representa por lo tanto el compuesto de la fórmula siguiente:The abbreviation Phe represents the alpha-amino acid phenylalanine. Phe-NCA therefore represents the compound of the following formula:
Se procede como en el ejemplo 1, con la diferencia de que la temperatura se establece a -17 \pm 1ºC con:Proceed as in Example 1, with the difference that the temperature is set at -17 ± 1 ° C with:
- 427 g de THF,- 427 g of THF,
- 25 g (0,131 moles) de D-Phe-NCA,- 25 g (0.131 moles) of D-Phe-NCA,
- 0,07 g (0,65 mmoles) de TEDA,- 0.07 g (0.65 mmol) of TEDA,
y una disolución de 34,2 g (0,157 moles) de (Boc)_{2}O en 21,5 g de THF.and a solution of 34.2 g (0.157 mol) of (Boc) 2 O in 21.5 g of THF.
Después de la filtración y del secado, se recuperan 24,1 g (rendimiento de 63%) del producto según la estructura RMN^{1}H esperada, y cuya pureza medida mediante GPC es de 95,2%.After filtration and drying, it is recover 24.1 g (63% yield) of the product according to the expected 1 H NMR structure, and whose purity measured by GPC It is 95.2%.
Ejemplo 4Example 4
En un reactor de 1 litro de doble cámara equipado con un criotermostato, un embudo de goteo, un sistema de circulación de nitrógeno, una agitación mecánica y una sonda termométrica, se introducen después de obtener un ambiente inerte con nitrógeno y de enfriar hasta -5 \pm 2ºC:In a 1 liter double chamber reactor equipped with a cryotmostat, a drip funnel, a system of nitrogen circulation, mechanical agitation and a probe thermometric, are introduced after obtaining an inert environment with nitrogen and cooling to -5 ± 2 ° C:
- 204 g de THF,- 204 g of THF,
- 20,0 g (0,141 moles) de Val-NCA,- 20.0 g (0.141 mol) of Val-NCA,
- 0,078 g (0,7 mmoles) de TEDA.- 0.078 g (0.7 mmol) of TEDA.
El medio de reacción se agita durante 30 minutos, y después se introducen lentamente 27,1 g (0,167 moles) de dicarbonato de dietilo [(EtOC)_{2}O] durante 1 hora mediante un embudo de goteo, regulando la temperatura a -5ºC \pm 2ºC. Aparece una ligera liberación de gas.The reaction medium is stirred for 30 minutes, and then slowly introduce 27.1 g (0.167 moles) of diethyl dicarbonate [(EtOC) 2 O] for 1 hour by means of a drip funnel, regulating the temperature at -5ºC ± 2 ° C A slight gas release appears.
El medio de reacción se mantiene con agitación durante 1 hora después del final del goteo de (EtOC)_{2}O.The reaction medium is maintained with stirring. for 1 hour after the end of the drip of (EtOC) 2 O.
El THF se concentra a una temperatura del medio de reacción de 18 a 26ºC a una presión de 140 a 160 milibares.THF is concentrated at a medium temperature reaction from 18 to 26 ° C at a pressure of 140 to 160 millibars.
Se añaden 220 ml de heptano B a una temperatura de 25ºC, y se vierte en una gran cantidad de agua helada. El producto precipita. Se filtra en un filtro nº 3 sinterizado en una atmósfera de nitrógeno. El producto se seca en un horno al vacío a una temperatura de 25 \pm 5ºC.220 ml of heptane B are added at a temperature of 25 ° C, and poured into a large amount of ice water. He product precipitates. It is filtered on a filter # 3 sintered in a nitrogen atmosphere The product is dried in a vacuum oven at a temperature of 25 ± 5 ° C.
Se obtienen así 20,1 g (rendimiento de 67%) de un polvo blanco, cuyos espectros de RMN^{1}H y de RMN^{13}C son conformes a la estructura esperada.20.1 g (67% yield) of a white powder, whose 1 H NMR and 13 C NMR spectra are according to the expected structure.
Claims (15)
- i)i)
- filtrar el medio de reacción;filter the reaction medium;
- ii)ii)
- eliminar al menos 80%, de forma ventajosa aproximadamente 90%, del disolvente mediante evaporación a presión reducida; y despuéseliminate at least 80%, so advantageously about 90%, of the solvent by evaporation at reduced pressure; and then
- iii)iii)
- agregar un compuesto no-disolvente, en una cantidad equivalente a la cantidad del disolvente de reacción eliminada mediante evaporación, a fin de precipitar el UNCA de la fórmula I; yadd a compound non-solvent, in an amount equivalent to the amount of reaction solvent removed by evaporation, in order to precipitate the UNCA of formula I; Y
- iv)iv)
- recuperar el UNCA de fórmula I mediante filtración, después de eliminar dichos grupos protectores si es necesario.retrieve the UNCA of formula I by filtration, after removing said protecting groups if required.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0310101 | 2003-08-22 | ||
FR0310101A FR2858976B1 (en) | 2003-08-22 | 2003-08-22 | PROCESS FOR OBTAINING ALPHA-AMINOACIDE N-CARBOXYANHYDRIDES WITH URETHANE PROTECTION |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2298827T3 true ES2298827T3 (en) | 2008-05-16 |
Family
ID=34112854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES04786315T Expired - Lifetime ES2298827T3 (en) | 2003-08-22 | 2004-08-17 | PROCEDURE FOR OBTAINING N-CARBOXIANHYDRIDES FROM ALPHA-AMINO ACIDS PROTECTED WITH URETHANE. |
Country Status (13)
Country | Link |
---|---|
US (1) | US7667051B2 (en) |
EP (1) | EP1660466B1 (en) |
JP (1) | JP2007503419A (en) |
KR (1) | KR20060120590A (en) |
CN (1) | CN1839123A (en) |
AT (1) | ATE383348T1 (en) |
CA (1) | CA2536308A1 (en) |
DE (1) | DE602004011235T2 (en) |
DK (1) | DK1660466T3 (en) |
ES (1) | ES2298827T3 (en) |
FR (1) | FR2858976B1 (en) |
MX (1) | MXPA06002113A (en) |
WO (1) | WO2005021517A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008064477A1 (en) | 2006-11-28 | 2008-06-05 | G3 Genuine Guide Gear Inc. | Apparatus for attaching climbing skins |
FR2913978B1 (en) * | 2007-03-21 | 2009-07-03 | Centre Nat Rech Scient | PROCESS FOR SYNTHESIZING PEPTIDES WITHOUT SOLVENT |
FR2928372B1 (en) * | 2008-03-10 | 2010-12-31 | Solvay | PEPTIDE SYNTHESIS METHOD |
CN110988246B (en) * | 2019-11-29 | 2022-03-08 | 荆门医药工业技术研究院 | Method for detecting contents of Z-L-valine and intermediate (S) -4-isopropyloxazole-2, 5-diketone thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5028693A (en) * | 1988-03-11 | 1991-07-02 | Bioresearch, Inc. | Urethane-protected amino acid-N-carboxyanhydrides |
US4946942A (en) | 1988-03-11 | 1990-08-07 | Bioresearch, Inc. | Urethane-protected amino acid-N-carboxyanhydrides |
ES2129398T3 (en) * | 1990-12-20 | 1999-06-16 | Siemens Ag | PROCEDURE FOR OBTAINING N-TERC-BUTOXI-CARBONILMALEINIMIDA. |
GB9604669D0 (en) * | 1996-03-05 | 1996-05-01 | Ciba Geigy Ag | Chemical compounds |
DK1189971T3 (en) * | 1999-06-17 | 2005-07-11 | Univ Gent | Functional poly-alpha-amino acid derivatives suitable for modifying biologically active materials and their use |
-
2003
- 2003-08-22 FR FR0310101A patent/FR2858976B1/en not_active Expired - Fee Related
-
2004
- 2004-08-17 WO PCT/FR2004/002148 patent/WO2005021517A1/en active IP Right Grant
- 2004-08-17 ES ES04786315T patent/ES2298827T3/en not_active Expired - Lifetime
- 2004-08-17 DK DK04786315T patent/DK1660466T3/en active
- 2004-08-17 AT AT04786315T patent/ATE383348T1/en not_active IP Right Cessation
- 2004-08-17 US US10/569,320 patent/US7667051B2/en not_active Expired - Fee Related
- 2004-08-17 CN CNA2004800241572A patent/CN1839123A/en active Pending
- 2004-08-17 JP JP2006524387A patent/JP2007503419A/en active Pending
- 2004-08-17 KR KR1020067003457A patent/KR20060120590A/en not_active Application Discontinuation
- 2004-08-17 EP EP04786315A patent/EP1660466B1/en not_active Expired - Lifetime
- 2004-08-17 MX MXPA06002113A patent/MXPA06002113A/en unknown
- 2004-08-17 DE DE602004011235T patent/DE602004011235T2/en not_active Expired - Lifetime
- 2004-08-17 CA CA002536308A patent/CA2536308A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2536308A1 (en) | 2005-03-10 |
MXPA06002113A (en) | 2006-05-31 |
DE602004011235T2 (en) | 2009-01-02 |
FR2858976B1 (en) | 2006-02-10 |
KR20060120590A (en) | 2006-11-27 |
DE602004011235D1 (en) | 2008-02-21 |
ATE383348T1 (en) | 2008-01-15 |
EP1660466A1 (en) | 2006-05-31 |
FR2858976A1 (en) | 2005-02-25 |
EP1660466B1 (en) | 2008-01-09 |
US20060287534A1 (en) | 2006-12-21 |
CN1839123A (en) | 2006-09-27 |
DK1660466T3 (en) | 2008-05-05 |
JP2007503419A (en) | 2007-02-22 |
US7667051B2 (en) | 2010-02-23 |
WO2005021517A1 (en) | 2005-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0357750B1 (en) | Urethane-protected amino acid-n-carboxyanhydrides | |
US8884009B2 (en) | Process for making bortezomib and intermediates for the process | |
HU201032B (en) | Process for production of izoxasoles hindering transglumatinase and medical compositions containing them | |
JP6703669B2 (en) | Method for producing leuprorelin | |
CA2383184A1 (en) | A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2 | |
US20220089522A1 (en) | Method of preparing a don prodrug from l-glutamic acid | |
DK154653B (en) | Method for preparation of the pentapeptide H-ARG-X-Z-Y- TYR-R during solution synthesis | |
AU2002310004B2 (en) | Uronium and immonium salts for peptide coupling | |
ES2298827T3 (en) | PROCEDURE FOR OBTAINING N-CARBOXIANHYDRIDES FROM ALPHA-AMINO ACIDS PROTECTED WITH URETHANE. | |
ES2410267T3 (en) | Pseudoproline dipeptides | |
Sureshbabu et al. | Protection reactions | |
EP1160236B1 (en) | Production of mixed acid anhydride and amine compound | |
AU2002310004A1 (en) | Uronium and immonium salts for peptide coupling | |
US7612209B2 (en) | Pseudo proline dipeptides | |
US3592836A (en) | Aryloxycarbonyl fluorides and amino acids and their production | |
HU221619B1 (en) | Process for synthetise peptides and intermediates thereof | |
Haidukevich et al. | Synthesis of acyl derivatives of prolyl-leucinamides | |
AU2018311521A1 (en) | Process for preparing 1 -(((Z)-(1 -(2-aminothiazol-4-yl)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxooxazolidin-3-y l)methyl)-1 -sulfoazetidin-3- yl)amino)ethylidene)amino)oxy)cyclopropane carboxylic acid | |
NZ322731A (en) | Acylated enol derivatives of alpha-ketoesters and alpha-ketoamides | |
US5942601A (en) | Peptide synthesis with sulfonyl protecting groups | |
US20240109875A1 (en) | Novel method for synthesizing nca compounds | |
US20240174713A1 (en) | Peptide synthesis method involving sterically hindered mixed anhydride intermediate | |
US7528228B2 (en) | Method for synthesizing peptides comprising at least one glycine molecule | |
WO2016038104A1 (en) | Novel non-natural amino acids, their process of preparation and uses thereof | |
KR20010053804A (en) | A process for producing amine with t-Butoxycarbonyl group |